Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001015820-25-000054
Filing Date
2025-08-15
Accepted
2025-08-15 16:52:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4876
  Complete submission text file 0001015820-25-000054.txt   6324
Mailing Address HULSTERWEG 82 PL VENLO P7 5912
Business Address HULSTERWEG 82 PL VENLO P7 5912 31-77-35566-00
QIAGEN N.V. (Subject) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38332 | Film No.: 251225389
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Bernard Thierry (Reporting) CIK: 0001815490 (see all company filings)

Type: 144